KR101778260B1 - Preparation Method for Kimchi with High GABA Content - Google Patents
Preparation Method for Kimchi with High GABA Content Download PDFInfo
- Publication number
- KR101778260B1 KR101778260B1 KR1020160008856A KR20160008856A KR101778260B1 KR 101778260 B1 KR101778260 B1 KR 101778260B1 KR 1020160008856 A KR1020160008856 A KR 1020160008856A KR 20160008856 A KR20160008856 A KR 20160008856A KR 101778260 B1 KR101778260 B1 KR 101778260B1
- Authority
- KR
- South Korea
- Prior art keywords
- kimchi
- gaba
- content
- lactobacillus
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000021109 kimchi Nutrition 0.000 title claims abstract description 103
- 238000002360 preparation method Methods 0.000 title claims description 17
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title abstract description 152
- 229960003692 gamma aminobutyric acid Drugs 0.000 title abstract description 77
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000011194 food seasoning agent Nutrition 0.000 claims abstract description 23
- 241000894006 Bacteria Species 0.000 claims abstract description 18
- 239000004310 lactic acid Substances 0.000 claims abstract description 17
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 17
- 239000004278 EU approved seasoning Substances 0.000 claims abstract description 6
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims abstract description 5
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 claims abstract description 5
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 14
- 241000186685 Lactobacillus hilgardii Species 0.000 claims description 13
- 240000001462 Pleurotus ostreatus Species 0.000 claims description 12
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 12
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 4
- 240000001929 Lactobacillus brevis Species 0.000 claims description 2
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 2
- 241000186679 Lactobacillus buchneri Species 0.000 claims description 2
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 2
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 2
- 241000692139 Lactobacillus rennini Species 0.000 claims description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- 241000186612 Lactobacillus sakei Species 0.000 claims description 2
- 241000186610 Lactobacillus sp. Species 0.000 claims description 2
- 241000178948 Lactococcus sp. Species 0.000 claims description 2
- 241000192129 Leuconostoc lactis Species 0.000 claims description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 2
- 241001627205 Leuconostoc sp. Species 0.000 claims description 2
- 244000057717 Streptococcus lactis Species 0.000 claims description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 239000010779 crude oil Substances 0.000 abstract 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 75
- 230000000052 comparative effect Effects 0.000 description 27
- 229930195712 glutamate Natural products 0.000 description 24
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 23
- 230000032683 aging Effects 0.000 description 22
- 230000000694 effects Effects 0.000 description 10
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 7
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000005070 ripening Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B7/00—Preservation of fruit or vegetables; Chemical ripening of fruit or vegetables
- A23B7/10—Preserving with acids; Acid fermentation
- A23B7/105—Leaf vegetables, e.g. sauerkraut
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/038—Gamma-amino butyric acid
-
- A23Y2220/00—
-
- A23Y2240/00—
-
- A23Y2260/00—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Storage Of Fruits Or Vegetables (AREA)
Abstract
본 발명은 숙성된 김치 내에서 가바함량을 증가시킬 수 있는 김치의 제조 방법에 관한 것으로, 보다 상세하게는 김치의 양념을 혼합하여 제조한 배합 양념에 유산균을 접종하여 발효시킨 후, 발효된 배합 양념을 절임 배추에 버무려 제조하는 것을 특징으로 하는 GABA 고함량 김치의 제조 방법에 관한 것이다.The present invention relates to a method for producing kimchi which can increase the amount of the crude oil in the aged kimchi. More specifically, the present invention relates to a method for producing kimchi, which comprises fermenting lactic acid bacteria inoculated with a seasoning prepared by mixing kimchi seasonings, To a pickled Chinese cabbage. The present invention also relates to a method for producing a high-content GABA kimchi.
Description
본 발명은 숙성된 김치 내에서 가바함량을 증가시킬 수 있는 김치의 제조 방법에 관한 것이다.
The present invention relates to a method of producing a kimchi which can increase the content of guava in an aged kimchi.
감마-아미노부티릭산(GABA, γ-aminobutyric acid)은 자연계에 분포하는 비단백질성 아미노산의 일종으로 뇌나 척수와 같은 중추신경계의 필수 구성요소로 알려져 있으며, 주된 억제성 신경전달물질(inhivitory neurotransmitter)로 알려져 있다. GABA는 많은 생리조절에 관여하는데 동물의 경우 뇌의 혈류를 활발하게 하고 뇌에 산소 공급량을 증가시켜 뇌세포의 대사기능을 촉진시키며, 혈액내의 중성지방을 줄이고 간기능을 개선시켜 고혈압의 예방과 같은 성인병 예방 등에 효과가 있으며, 통증완화, 우울, 불안 등에 대한 신경안정 기능이 있다. 스트레스에 시달리는 현대인, 특히 수험생, 알코올 과다 섭취자 등의 경우에는, 뇌와 혈중 GABA농도가 낮은 것으로 보고되어 있으며, 체내 GABA농도의 극심한 부족은 발작, 경련, 간질 증세를 일으킨다. 이와 같은 생리작용으로 인하여 GABA는 정맥주사제로 뇌졸중, 머리외상, 뇌동맥 후유증에 있어 뇌혈류 개선 및 뇌대사 증진 작용에 사용되고 있으며, 경구 처방약으로도 판매되고 있다. Gamma-aminobutyric acid (GABA) is a naturally occurring non-proteinaceous amino acid that is known to be an essential component of the central nervous system such as the brain and spinal cord. It is a major inhibitory neurotransmitter It is known. GABA is involved in many physiological functions. In animals, it stimulates the blood flow of the brain and increases the supply of oxygen to the brain to promote the metabolic function of the brain cells. It reduces the triglyceride in the blood and improves the liver function, Prevention of adult diseases, etc. It has neuromuscular functions for pain relief, depression and anxiety. In modern people who are suffering from stress, especially examinees, excessive alcohol consumption, brain and blood GABA levels are reported to be low, and a severe shortage of GABA in the body causes seizures, convulsions, and epilepsy. Due to this physiological effect, GABA is an intravenous injection which is used for cerebral blood flow improvement and brain metabolism enhancement in stroke, head trauma, sequelae of cerebral artery, and is also sold as an oral prescription medicine.
최근 들어서는 의약품으로서의 용도 뿐 아니라 기능성 식품 소재로서의 관심 또한 고조되고 있다. GABA는 각종 채소, 과일, 쌀, 콩 등에 널리 분포되어 있는 것으로 이를 식품을 통해 보충할 경우 필요량은 하루 500-3000mg이며, 하루에 GABA 80mg으로 혈압강하가 가능하다고 알려져 있으나 식품 자체로는 그 함량이 너무 낮아 생리작용을 나타내기 어렵다. 반면, 화학 합성에 의해 제조된 GABA는 식욕부진, 변비, 설사 등 부작용이 우려된다. 이에 최근 일본에서는 GABA 함량을 높인 녹차, 쌀배아, 발아현미 등이 판매되면서 식품업계와 소비자의 관심이 고조되고 있다.
Recently, interest as a functional food material has been increasing not only as a medicine but also as a medicine. GABA is widely distributed in various vegetables, fruits, rice, and beans. When it is supplemented through food, the necessary amount is 500-3000 mg per day, and it is known that the blood pressure can be lowered to 80 mg of GABA per day. However, It is too low to show physiological function. On the other hand, GABA produced by chemical synthesis is concerned about side effects such as anorexia, constipation, and diarrhea. In recent years, interest in the food industry and consumers has been rising in Japan as green tea, rice embryo, and germinated brown rice, which have increased GABA content, are sold.
김치는 소금에 절인 무, 배추 등에 각종 양념을 첨가한 후 숙성시켜 발효시킨 우리나라의 대표적인 전통발효식품으로, 2011년 국민 건강통계 결과에 의하면 한국인이 1일 평균 68.6g 섭취한 한국인에게 중요한 식품 중 하나이다. 다양한 재료에서 오는 성분과 유산균 등이 풍부하여 동맥경화 예방, 항암 · 항염증 등 기능성 식품으로 기대되고 있다. 이러한 이유로 김치는 세계 5대 건강식품 중의 하나로 선정되었으며, Codex 국제 식품 규격을 획득하였다.Kimchi is one of Korea's representative traditional fermented foods that have been fermented after adding various kinds of seasonings such as salted radishes and cabbages. It is one of the important foods for Koreans who consumed an average of 68.6g per day according to the 2011 National Health Statistics . It is expected to be a functional food such as anti-arteriosclerosis, anti-cancer and anti-inflammation, because it comes from various ingredients and lactic acid bacteria. For this reason, kimchi has been selected as one of the top five health foods in the world and has acquired the Codex international food standard.
김치의 발효에 있어 중요한 역할을 하는 Lactobacillus 속 균주는 GABA를 생산하는 것으로 알려지면서, 김치에서 분리한 젖산균을 실제 식품에 적용하여 식품 중의 GABA 함량을 높이는 기술 또한 다수 보고된 바 있다(등록특허 제0478491호, 등록특허 제0910657호). Lactobacillus 속은 포자를 형성하지 않고, 혐기성 또는 통성혐기성의 그람 양성 세균으로, 인체에 유익한 유산균으로서 발효 유제품의 starter로 널리 사용되고 있다. Lactobacillus strain, which plays an important role in the fermentation of kimchi, is known to produce GABA, and a number of techniques for increasing the GABA content in food by applying lactic acid bacteria isolated from kimchi to actual foods have been reported (Patent No. 0478491 No. 0910657). Lactobacillus spp. Is a spore-free, anaerobic or thermophilic anaerobic Gram-positive bacterium, and is widely used as starter of fermented dairy products as lactic acid bacteria beneficial to the human body.
김치의 기능성 성분을 더욱 강화하려는 연구들이 활발히 이루어 지면서, 김치 자체 내에 GABA 함량을 높이고자 하는 연구들도 보고되고 있다. 이들 연구는 GABA 변환능력이 우수한 균주 스타터로 김치 제조 시 첨가하는 방법이나 MSG(L-글루타민산소듐)와 같은 GABA의 전구체를 추가하는 것이다. 그러나 최근 인체에 무해함이 주장되고 있긴 하지만 화학조미료인 MSG의 사용을 꺼리는 추세에 적합하지 않다. 또한 이들 방법에 의해 제조된 김치는 GABA의 함량을 높이기 위해서 균주의 생육에 적합한 최소 온도를 제공하기 위해 15℃ 정도의 온도에서 숙성시켜야 하므로 김치가 쉽게 시어져 김장 김치와 같이 장기간 보관하는 김치에 적용하는 데에는 문제가 있고, 여전히 생리활성을 나타내기에는 김치내 GABA 함량이 부족하였다.
Studies have been actively carried out to further enhance the functional components of kimchi, and studies have been reported to increase the content of GABA in kimchi itself. These studies are excellent strains of GABA-transforming strains. They are either added during the manufacture of kimchi or added precursors of GABA such as MSG (sodium L-glutamate). However, although it is claimed to be harmless to humans recently, it is not suitable for the trend of avoiding the use of MSG, a chemical seasoning. In order to increase the content of GABA, the kimchi prepared by these methods should be aged at a temperature of about 15 ° C to provide a minimum temperature suitable for the growth of the strain, so that the kimchi can be easily applied to kimchi stored for a long time such as kimchi And there was still insufficient GABA content in kimchi to show physiological activity.
본 발명은 10℃이하의 저온의 숙성 과정에서도 김치 내 GABA의 함량을 효과적으로 증가시킬 수 있는 김치의 제조 방법을 제공하는 것을 목적으로 한다.
It is an object of the present invention to provide a method for producing kimchi which can effectively increase the content of GABA in kimchi even at a low temperature aging of 10 ° C or lower.
전술한 목적을 달성하기 위한 본 발명은 김치의 양념을 혼합하여 제조한 배합 양념에 유산균을 접종하여 발효시킨 후, 발효된 배합 양념을 절임 배추에 버무려 제조하는 것을 특징으로 하는 GABA 고함량 김치의 제조 방법에 관한 것이다.In order to achieve the above object, the present invention provides a method for producing a GABA high-content kimchi, which comprises fermenting a fermented lactic acid bacterium in a mixed seasoning prepared by mixing seasonings of Kimchi, and then fermenting the fermented seasoning to a pickled Chinese cabbage ≪ / RTI >
본 발명에서 상기 유산균으로는 GABA를 생산하는 것으로 알려진 Lactobacillus sp., Lactococcus sp. 또는 Leuconostoc sp.의 유산균을 사용할 수 있다. 보다 구체적으로는 Lactobacillus hilgardii, Lactobacillus sakei, Lactobacillus paracasei, Lactobacillus rennini, Lactobacillus buchneri, Lactobacillus brevis, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus Lactis, Leuconostoc mesenteroides, Leuconostoc lactis로 이루어진 군으로부터 선택된 하나 이상을 사용할 수 있으며, 이에 한정되지 않고 예시되지 않았다고 하더라도 GABA 생산기능이 있는 유산균주라면 어느 것이라도 사용할 수 있음은 당연하다.
In the present invention, Lactobacillus sp. , Lactococcus sp. Or Leuconostoc sp. Of lactic acid bacteria can be used. More specifically, one or more selected from the group consisting of Lactobacillus hilgardii , Lactobacillus sakei , Lactobacillus paracasei , Lactobacillus rennini , Lactobacillus buchneri , Lactobacillus brevis , Lactobacillus plantarum , Lactobacillus rhamnosus , Lactococcus lactis , Leuconostoc mesenteroides and Leuconostoc lactis may be used. It is of course possible to use any of the lactic acid bacteria having GABA production function even if not exemplified.
상기 배합 양념은 김치의 제조에 사용되는 각종 부재료의 혼합물로, 배합되는 종류나 배합비는 식성이나 취향에 따라 적절히 선택될 수 있는 것으로 상세한 설명은 생략한다. 하기 실시예에서는 김치의 제조에 사용되는 기본 양념을 기준으로 그 예를 기재하였으나, 이에 한정되지 않고 적절한 부재료를 가감할 수 있다. 본 발명에서 상기 배합 양념의 발효는 20~40℃에서 12~48시간 이루어지는 것이 바람직하다. 배합 양념의 발효 시간이 너무 짧은 경우에는 GABA 함량 증가를 위한 충분한 효과를 얻을 수 없었으며, 48시간 이상 숙성하는 것은 공정 효율면에서 유용하지 않았다. 또한 발효시간은 상기 범위내에서도 발효 온도를 고려하여 적절히 조절할 수 있음은 당연하다.The compounding seasoning is a mixture of various kinds of ingredients used in the manufacture of kimchi, and the kind and the compounding ratio to be compounded can be appropriately selected according to food or taste, and detailed description is omitted. In the following examples, an example is described based on the basic seasoning used in the manufacture of kimchi, but the present invention is not limited to this and suitable ingredients can be added or subtracted. In the present invention, it is preferable that fermentation of the combined seasonings is performed at 20 to 40 ° C for 12 to 48 hours. When the fermentation time was too short, sufficient effect for increasing the GABA content could not be obtained and aging for more than 48 hours was not useful in terms of process efficiency. It is a matter of course that the fermentation time can be appropriately adjusted in consideration of the fermentation temperature even within the above range.
통상 김치는 숙성 과정에서 GABA의 함량이 증가하는 것으로 알려져 있으나, 10℃이하의 저온에서 숙성하는 경우에는 하기 비교예 1에서 확인할 수 있듯이 GABA 숙성 기간이 경과하여도 GABA의 함량에 큰 변화가 없었다. GABA를 생산하는 것으로 알려진 유산균을 스타터로 김치에 접종하는 경우에도 마찬가지 였다(비교예 2 참조). 이는 김치 숙성온도가 낮아 유산균주의 최적생육온도와 GABA 생합성 관련 효소인 Glutamate dehydrogenase(GAD)의 최적활성온도인 30℃보다 크게 낮아, L. hilgardii MYA-9의 생육 또는 GAD의 활성이 나타나지 않은 것으로 판단된다. 즉, 종래기술에서 유산균주를 접종하여 김치를 제조하는 경우에는 15℃ 내외의 온도에서 숙성시키기 때문에 GABA 함량의 증가에 문제가 없었으나, 하기 실시예에서와 같이 저온 숙성의 경우에는 종래기술에 의한 GABA 함량 증가 효과를 얻을 수 없었다. 이에 비해 본 발명의 방법에 의해 배합 양념에 유산균을 접종하여 발효시킨 후 제조한 김치의 경우에는 배합 양념의 발효과정에서도 GABA가 생성될 뿐 아니라 저온 숙성과정에서도 GABA 함량이 크게 증가하여 GABA 고함량 김치를 제조하는 것이 가능하였다. 또한, 배합 양념을 발효한 후 멸균하여 제조한 김치(비교예 3)에서는 상기 효과가 나타나지 않았다.In general, the content of GABA is known to increase in the fermentation process. However, in the case of fermentation at a low temperature of 10 ° C or less, there is no significant change in the content of GABA even after the fermentation period of GABA has elapsed as shown in Comparative Example 1 below. The same was true for the case of inoculating Kimchi with a lactic acid bacteria known to produce GABA as a starter (see Comparative Example 2). It was judged that the growth of L. hilgardii MYA-9 or the activity of GAD did not appear because the optimum temperature of lactic acid bacteria and the optimal activity temperature of glutamate dehydrogenase (GAD), which is an enzyme related to GABA biosynthesis, do. That is, in the case where the lactic acid bacteria are inoculated in the prior art to produce kimchi, there is no problem in increasing the GABA content because it is aged at a temperature of about 15 ° C. However, in the case of low temperature aging, The effect of increasing GABA content could not be obtained. On the other hand, in the case of the fermented Kimchi fermented with lactic acid bacteria by the method of the present invention, GABA was produced not only in the fermentation process of the seasoning but also the GABA content was significantly increased in the low temperature fermentation process, . ≪ / RTI > In addition, the above effect was not observed in the kimchi prepared by fermenting the mixed seasonings and sterilized (Comparative Example 3).
따라서 본 발명에 의해 제조된 김치는 저온에서 숙성시키더라도 숙성과정에서 GABA 함량이 유효하게 증가하였으며, 숙성온도는 0~25℃인 것이 바람직하였다. 숙성온도가 증가할수록 유산균의 생육과 GAD 활성이 증가하므로 GABA 증가 효과는 더욱 현저하였다. 숙성온도가 0℃보다 낮아진다면 GABA 생성효율이 저하될 뿐 아니라 김치가 얼어 오히려 풍미를 해칠 수 있으며, 숙성온도가 25℃를 넘는다면 GABA 생성은 증가하겠지만 쉽게 시어져버린다.Therefore, the kimchi prepared according to the present invention effectively increased the GABA content during aging even though it was aged at a low temperature, and the aging temperature was preferably 0 to 25 ° C. As the ripening temperature increased, the growth of lactic acid bacteria and the activity of GAD increased, so that the effect of increasing GABA was more remarkable. If the aging temperature is lower than 0 ° C, not only the GABA production efficiency is lowered but also the kimchi freezes and the flavor may be deteriorated. If the aging temperature exceeds 25 ° C, the GABA production will increase but it is easily exacerbated.
특히 본 발명의 김치 제조 시에는 배합 양념에 느타리 버섯의 물 추출물이 함유되는 것이 바람직하였다. 느타리 버섯 또는 양송이 버섯의 물 추출물은 김치 내 GABA의 함량을 크게 증가시켰으며, 특히 숙성기간의 경과에 따른 GABA 함량의 변화에 큰 영향을 미쳤다. 하기 실시예에 기재하지는 않았지만, 느타리 버섯 또는 양송이 버섯 이외의 표고버섯, 팽이버섯, 머쉬마루의 경우에는 GABA 함량의 변화에 큰 영향을 미치지 않았다. 양송이 버섯의 물 추출물은 김치의 GABA 함량을 역시 크게 증가시키기는 하였으나, 느타리 버섯보다는 그 효과가 크지 않았다.Particularly, it is preferable that the water extract of Pleurotus ostreatus is contained in the seasoning of kimchi. Water extracts of Oyster mushroom or Mushroom mushroom significantly increased the content of GABA in kimchi, especially the change of GABA content with aging. In the case of mushroom, mushroom, and mushroom other than oyster mushroom or mushroom mushroom, the change of GABA content was not greatly influenced although it was not described in the following examples. The water extract of Mushroom mushroom significantly increased the GABA content of kimchi, but the effect was not greater than that of oyster mushroom.
이상과 같이 본 발명에 의하면 저온에서 김치를 숙성하는 경우에도 GABA의 함량 증가가 우수하므로 장기간 보관이 가능하면서도 GABA 함량이 높은 김치를 제조할 수 있다.
As described above, according to the present invention, even when the kimchi is aged at a low temperature, since the content of GABA is increased, it is possible to produce a kimchi having a high GABA content while being stored for a long period of time.
도 1은 비교예 1의 김치의 숙성시간 경과에 따른 김치와 김치국물 내 GABA 및 glutamate의 함량 변화를 보여주는 그래프.
도 2는 비교예 2의 김치의 숙성시간 경과에 따른 김치와 김치국물 내 GABA 및 glutamate의 함량 변화를 보여주는 그래프.
도 3은 제조예 1의 김치의 숙성시간 경과에 따른 김치와 김치국물 내 GABA 및 glutamate의 함량 변화를 보여주는 그래프.
도 4는 비교예 3의 김치의 숙성시간 경과에 따른 김치와 김치국물 내 GABA 및 glutamate의 함량 변화를 보여주는 그래프.
도 5는 비교예 4의 김치의 숙성시간 경과에 따른 김치와 김치국물 내 GABA 및 glutamate의 함량 변화를 보여주는 그래프.
도 6은 제조예 2의 김치의 숙성시간 경과에 따른 김치와 김치국물 내 GABA 및 glutamate의 함량 변화를 보여주는 그래프.FIG. 1 is a graph showing changes in content of GABA and glutamate in kimchi and kimchi broth according to aging time of the kimchi of Comparative Example 1. FIG.
FIG. 2 is a graph showing changes in content of GABA and glutamate in kimchi and kimchi broth according to aging time of the kimchi of Comparative Example 2. FIG.
FIG. 3 is a graph showing changes in content of GABA and glutamate in kimchi and kimchi broth according to aging time of the kimchi of Preparation Example 1. FIG.
FIG. 4 is a graph showing changes in content of GABA and glutamate in kimchi and kimchi broth according to aging time of the kimchi of Comparative Example 3. FIG.
FIG. 5 is a graph showing changes in content of GABA and glutamate in kimchi and kimchi broth according to aging time of the kimchi of Comparative Example 4. FIG.
6 is a graph showing changes in the contents of GABA and glutamate in kimchi and kimchi broth according to aging time of the kimchi of Preparation Example 2. FIG.
이하 첨부된 실시예를 들어 본 발명을 보다 상세히 설명한다. 그러나 이러한 실시예는 본 발명의 기술적 사상의 내용과 범위를 쉽게 설명하기 위한 예시일 뿐, 이에 의해 본 발명의 기술적 범위가 한정되거나 변경되는 것은 아니다. 이러한 예시에 기초하여 본 발명의 기술적 사상의 범위 안에서 다양한 변형과 변경이 가능함은 당업자에게는 당연할 것이다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, these embodiments are merely examples for explaining the content and scope of the technical idea of the present invention, and thus the technical scope of the present invention is not limited or changed. It will be apparent to those skilled in the art that various changes and modifications can be made within the scope of the technical idea of the present invention based on these examples.
실시예 Example
김치 제조에 사용된 재료의 배합비는 하기 표 1과 같다. 배추는 통상의 방법에 의해 10% 소금물에 4~5시간 침지하여 절인 후, 흐르는 물에 세척하고 물을 뺀 후 사용하였다. 배합 양념은 배추 10kg을 기준으로 고춧가루 3컵반, 멸치액젓 1컵, 새우젓 1컵, 간마늘 1컵, 간생강 4밥숟가락, 설탕 4밥숟가락, 대파 200g, 양파 200g, 명태와 다시마를 우린 육수 1컵을 혼합하여 제조하였다. 육수는 물 3L에 명태 1마리와 10×10cm 다시마 한 조각을 넣고 2시간 끓여 제조하였다. 상기 방법에 의해 제조된 절임 배추와 배합 양념을 사용하여 하기 제조예 및 비교예에 제시된 방법에 따라 균주를 추가한 후 버무려 김치를 제조하였다. The blend ratio of the materials used in the manufacture of kimchi is shown in Table 1 below. The Chinese cabbage was immersed in 10% brine for 4 to 5 hours by a conventional method, and then washed in running water and water was used. Mixed spices consist of 3 cups of red pepper powder, 1 cup of anchovy sauce, 1 cup of shrimp sauce, 1 cup of liver garlic, 4 spices of liver ginger, 4 spoons of sugar, 200 g of onion, 200 g of onion, Cup. The broth was prepared by boiling 2 servings of 1 pollock and 10 × 10cm seaweed in 3 liters of water. Using the salted Chinese cabbage and the prepared seasoning prepared by the above method, the strain was added according to the methods shown in the following Preparations and Comparative Examples, and then the kimchi was prepared by kneading.
제조한 김치는 4℃의 저온실에 보관하여 숙성시키면서 숙성기간별(1, 2, 3, 4, 5, 6, 7, 10, 13, 16, 19일) 김치와 김치국물 내 유산균 생균수와 함께 GABA 및 glutamate 함량을 조사하였다. 유산균 생균수는 김치 1g을 생리식염수에 희석하여, MRS agar (proteose peptone No. 3 10.0 g, beef extract 10.0 g, yeast extract 5.0 g, dextrose 20.0 g, polysorbate80 1.0 g, ammonium citrate 2.0 g, sodium acetate 5.0 g, magnesium sulfate 0.1 g, manganese sulfate 0.05 g, dipotassium phosphate 2.0 g) 배지에 도말하여 30℃에서 48시간 배양 후 나타난 콜로니 수를 세어 계산하였다. The fermented kimchi was stored in a low temperature room at 4 ℃ and fermented for 1, 2, 3, 4, 5, 6, 7, 10, 13, 16, And glutamate content were investigated. 1 g of lactic acid bacteria was diluted in physiological saline, and 10 g of MRS agar (10.0 g of protease peptone No. 3, 10.0 g of beef extract, 5.0 g of yeast extract, 20.0 g of dextrose, 1.0 g of polysorbate 80, 2.0 g of ammonium citrate, g, magnesium sulfate 0.1 g, manganese sulfate 0.05 g, dipotassium phosphate 2.0 g), and cultured at 30 ° C for 48 hours.
김치와 김치국물의 GABA 및 glutamate 함량은 HPLC를 사용하여 분석하였다. HPLC는 Agilent 1200 series를 이용하였으며, 컬럼은 Zorbax Eclipse-AAA Columns(150 × 4.6 mm i.d., particle size 5 um)과 가드컬럼으로 Zorbax Eclipse-AAA 4-Pack(12.5 × 4.6 mm i.d., 5 um)을 사용하였다. UV detector를 사용하여 338nm 에서 검출하였으며, 컬럼 온도는 40℃로 맞추었다. 용매는 이동상(A) 40mM NaH2PO4,pH7.8과 이동상(B) Acetonitrile: Methanol: distillated water(45: 45: 10, v/v/v)를 사용하였으며 이동상의 gradient 조건은 0.0 min, 0% B; 0.0-1.9 min, 0% B; 1.9-21.1 min, 57% B; 21.1-21.6 min, 100% B; 21.6-25.0 min, 100% B; 25.0-25.1 min, 0% B; 25.1-32 min, 0%였다. 유속은 2ml/min으로 하였다. HPLC 분석을 위한 시료는 보다 상세하게는, 김치국물은 원심분리(13,000 rpm, 4℃, 10 min) 후 0.45um PTFE syringe filter를 이용하여 여과하여 HPLC분석하였다. 김치는 동결건조 후 100mg을 칭량하여 5% trichloroacetic acid 수용액으로 유리아미노산을 추출한 후 원심분리(13,000 rpm, 4℃, 10 min)하였다. 상등액을 0.45um PTFE syringe filter를 이용하여 여과하여 HPLC로 분석하였다.
The content of GABA and glutamate in Kimchi and Kimchi broth was analyzed by HPLC. The HPLC was carried out using Agilent 1200 series and the columns were Zorbax Eclipse-AAA Columns (150 × 4.6 mm id,
균주의 준비Preparation of strain
GABA 함량을 증가시킨 김치의 제조를 위하여 먼저 1% MSG를 함유하는 MRS broth에 L. hilgardii MYA-9(KCTC 21051)를 30℃에서 48시간 배양시킨 후 원심분리(4000 rpm, 4℃, 10 min)하여 균체만을 분리하였다. 분리된 균체는 생리식염수와 멸균수를 이용하여 2회 세척하였으며, 멸균수 10ml에 현탁시켜 접종에 사용하였다. 접종 농도는 1.2 × 106 cfu/ml가 되도록 하였다.
For the preparation of kimchi with increased GABA content, L. hilgardii MYA-9 (KCTC 21051) was incubated at 30 ° C for 48 hours in MRS broth containing 1% MSG and centrifuged (4000 rpm, 4 ° C, 10 min ). The isolated cells were washed twice with physiological saline and sterilized water, suspended in sterilized water (10 ml) and used for inoculation. The inoculation concentration was 1.2 × 10 6 cfu / ml.
비교예 1 : 종래방법에 의한 김치Comparative Example 1: Kimchi
배합 양념에 절임 배추를 버무려 김치를 제조한 후 4℃에서 숙성시키면서 숙성기간에 따른 김치와 김치국물 내의 유산균 생균수와 GABA 및 glutamate 함량을 측정하였다. The fermented kimchi was fermented at 4 ℃. The fermentation time of kimchi, kimchi broth and GABA and glutamate contents were measured.
표 1에서 확인할 수 있듯이 유산균 생균수는 숙성초기 1.1 × 106cfu/mL에서 19일 후 3.12 × 108cfu/mL로 숙성기간이 지남에 따라 100배 수준으로 증가하였다. 그러나 김치와 김치국물 내의 GABA및 glutamate 함량은 숙성시간이 경과하여도 뚜렷한 변화를 나타내지 않았다(도 1). 김치국물은 김치보다 glutamate의 함량이 다소 높았으나, GABA의 함량은 김치와 김치국물에서 서로 비슷하였다.As shown in Table 1, the number of lactic acid bacteria was increased from 1.1 × 10 6 cfu / mL in the early stage of fermentation to 3.12 × 10 8 cfu / mL after 19 days of fermentation. However, the contents of GABA and glutamate in kimchi and kimchi broth did not show any significant change even after aging (Fig. 1). The content of glutamate in kimchi soup was higher than that of kimchi, but the contents of GABA were similar in kimchi and kimchi soup.
비교예 2 : Comparative Example 2: L. hilgardiiL. hilgardii MYA-9를 접종한 김치 The kimchi inoculated with MYA-9
김치의 제조 시 배합 양념에 L. hilgardii MYA-9를 접종한 것을 제외하고는 비교예 1과 동일한 방법에 의해 김치를 제조하고 숙성시키면서 숙성기간에 따른 김치와 김치국물 내의 GABA 및 glutamate 함량을 측정하여 그 결과를 도 2에 도시하였다. 도 2에서 확인할 수 있듯이, 김치 및 김치국물 내 GABA및 glutamate함량은 숙성 19일 후에도 접종 초기와 차이를 보이지 않았으며, 무 접종구인 비교예 1과도 비슷한 수준을 유지하였다. 그 원인은 김치 숙성온도인 4℃는 L. hilgardii MYA-9의 최적생육온도인 36℃와 GABA 생합성 관련 효소인 Glutamate dehydrogenase(GAD)의 최적활성온도인 30℃보다 크게 낮아, L. hilgardii MYA-9의 생육 또는 GAD의 활성이 나타나지 않은 것으로 판단된다.
The kimchi was prepared and fermented in the same manner as in Comparative Example 1 except that L. hilgardii MYA-9 was inoculated into the prepared seasoning of kimchi, and the content of GABA and glutamate in kimchi and kimchi broth was measured The results are shown in Fig. As shown in FIG. 2, the content of GABA and glutamate in kimchi and kimchi broth did not show any difference from the initial stage of inoculation even after 19 days of aging, and remained similar to that of Comparative Example 1 which was not inoculated. The cause is 4 ℃ Kimchi ripening temperature is significantly lower than the optimum activation temperature of 30 ℃ L. hilgardii MYA-9 optimum growth temperature of 36 ℃ and GABA biosynthesis-related enzyme, Glutamate dehydrogenase (GAD) of, L. hilgardii MYA- 9 or the activity of GAD was not observed.
제조예 1 : 배합 양념을 Production Example 1: L. hilgardiiL. hilgardii MYA-9로 발효시킨 후 제조한 김치 After fermentation with MYA-9,
배합 양념에 L. hilgardii MYA-9를 접종한 후 30℃에서 24시간 발효시킨 후 사용한 것을 제외하고는 비교예 1과 동일한 방법에 의해 김치를 제조하고 숙성시키면서 숙성기간에 따른 김치와 김치국물 내의 GABA 및 glutamate 함량을 측정하여 그 결과를 도 3에 도시하였다. 비교예 1과 2는 숙성기간이 경과하여도 김치 또는 김치국물 내의 GABA 함량에 변화가 없었으나, 발효된 배합 양념을 사용한 김치는 김치가 숙성됨에 따라 GABA의 함량이 점차 증가하였다. 즉, 초기 GABA 함량이 김치는 101.38mg/100g에서 19일 숙성 후 168.05mg/100g으로 66.67mg/100g 증가하였고, 김치국물은 초기 108.46mg/100mL에서 19일 숙성 후 239.74 mg/100mL으로 131.28mg/100mL증가하여 비교예 1 및 비교예 2에 비해 함량이 현저히 증가한 것을 확인할 수 있었다. 또한 비교예 1과 2에서는 GABA에 비해 glutamate의 함량이 더 높았으나, 제조예 1에서는 glutamate에 비해 GABA의 함량이 훨씬 높았다.
Preparation of kimchi by the same method as in Comparative Example 1 except that L. hilgardii MYA-9 was inoculated into the mixed seasoning and fermented at 30 ° C for 24 hours, And glutamate content were measured. The results are shown in Fig. In Comparative Examples 1 and 2, there was no change in the GABA content in kimchi or kimchi broth even after the aging period. However, the content of GABA in kimchi fermented with seasoning increased gradually as kimchi was aged. That is, the initial GABA content increased 66.67 mg / 100 g to 168.05 mg / 100 g after kimchi ripening at 101.38 mg / 100 g for 19 days, and kimchi broth increased to 131.28 mg / 100 g after 23 days of aging at 108.46 mg / It was confirmed that the content was significantly increased as compared with Comparative Example 1 and Comparative Example 2. In addition, the content of glutamate was higher in Comparative Examples 1 and 2 than in GABA, but the content of GABA in Preparation Example 1 was much higher than that of glutamate.
비교예 3 : 배합 양념을 Comparative Example 3: L. hilgardiiL. hilgardii MYA-9로 발효시킨 후 멸균하여 제조한 김치 After fermentation with MYA-9 and sterilization,
발효된 배합 양념을 100℃에서 15분간 멸균하여 사용한 것을 제외하고는 제조예 1과 동일한 방법에 의해 김치를 제조하고 숙성시키면서 숙성기간에 따른 김치와 김치국물 내의 GABA 및 glutamate 함량을 측정하여 그 결과를 도 4에 도시하였다. GABA and glutamate contents in kimchi and kimchi broth were measured according to the fermentation period, while the kimchi was prepared and fermented in the same manner as in Preparation Example 1, except that the fermented seasoning was sterilized at 100 ° C for 15 minutes. Is shown in FIG.
도 4에서 김치의 제조 후 숙성 초기의 GABA 함량은 제조예 1에 대한 도 3에서와 유사한 수준이었으나, 제조예 1의 경우 숙성기간의 경과에 따라 GABA 함량이 증가한 것에 비해 비교예 3에서는 숙성기간의 경과에 따른 GABA 함량의 변화가 미미하였다. 이러한 경향은 특히 김치국물 내의 GABA 함량에서 더욱 명확하게 대비되어 숙성 초기의 GABA 함량은 비교예 3과 제조예 1이 유사하였으나, 숙성 19일째에는 GABA 함량이 2배 이상 차이가 있었다.
In FIG. 4, the GABA content at the early stage of fermentation after the preparation of kimchi was similar to that of Preparation Example 1, but the fermentation period of Preparation Example 1 increased the GABA content, whereas the fermentation period of Comparative Example 3 The changes of GABA content with the passage of time were insignificant. This tendency was particularly clear in the GABA content in the kimchi soup, and the GABA content in the early stage of ripening was similar to that of Comparative Example 3 and Preparation Example 1, but the GABA content was more than two times on the 19th day of ripening.
비교예 4 : 느타리 버섯 육수를 포함한 배합 양념으로 제조한 김치 Comparative Example 4: Oyster mushroom Kimchi prepared with mixed seasoning including broth
배합 양념 중 명태와 다시마를 우린 육수의 제조 시 물 3L 당 30g의 느타리 버섯을 추가로 넣어서 우려낸 육수를 사용한 것을 제외하고는 비교예 1과 동일한 방법에 의해 김치를 제조하고 숙성시켰다. 숙성기간에 따른 김치와 김치국물 내의 GABA 및 glutamate 함량은 도 5와 같다.In the preparation of the broth, the kimchi was prepared and fermented in the same manner as in Comparative Example 1, except that 30 g of mushroom per 3 L of water was further added to the broth. The content of GABA and glutamate in kimchi and kimchi broth according to the ripening period is shown in Fig.
도 5는 느타리 버섯을 사용하지 않았을 때에 비해 GABA 함량 및 glutamate의 함량이 약간 증가하긴 하였지만, 비교예 1과 마찬가지로 숙성기간의 경과에 따라 김치와 김치국물 모두에서 GABA 함량에 차이가 없음을 보여준다.
FIG. 5 shows that GABA content and glutamate content were slightly increased compared to when no oyster mushroom was used. However, as in Comparative Example 1, there was no difference in GABA content between kimchi and kimchi broth according to the aging period.
제조예 2 : 느타리 버섯 육수를 포함한 배합 양념을 Production Example 2: Oyster mushrooms L. hilgardiiL. hilgardii MYA-9로 발효시킨 후 제조한 김치 After fermentation with MYA-9,
배합 양념에 L. hilgardii MYA-9를 접종한 후 30℃에서 24시간 발효시킨 후 사용한 것을 제외하고는 비교예 4와 동일한 방법에 의해 김치를 제조하고 숙성시키면서 숙성기간에 따른 김치와 김치국물 내의 GABA 및 glutamate의 함량을 측정하여 그 결과를 도 6에 도시하였다. Preparation of kimchi by the same method as in Comparative Example 4 except that L. hilgardii MYA-9 was inoculated into the prepared sauce and fermented at 30 ° C for 24 hours, And glutamate were measured. The results are shown in Fig.
도 6에서 볼 수 있듯이, 숙성 초기의 GABA 및 glutamate의 함량은 비교예 4와 거의 유사하였으나, 숙성이 진행됨에 따라 크게 증가하여 김치는 초기 GABA 함량이 106.57mg/100g 에서 19일 숙성 후 195.16mg/100g 으로 88.59mg/100g 증가하였고, 김치국물도 초기 121.67mg/100mL에서 19일 숙성 후 295.46mg/100mL로 173.79mg/100mL의 증가효과를 나타내었다. As shown in FIG. 6, the content of GABA and glutamate in the early stage of aging was almost the same as that of Comparative Example 4, but it was greatly increased as the aging progressed. The initial GABA content of kimchi was 195.16 mg / 100g and 88.59mg / 100g, respectively. The kimchi broth also showed an increase of 173.79mg / 100mL at 121.67mg / 100mL and 295.46mg / 100mL after 19 days of fermentation.
비교예 1과 비교예 4를 비교하였을 때 숙성 초기의 GABA 및 glutamate의 함량차이에 비해 제조예 2에서의 GABA 및 glutamate의 함량이 현저히 증가한 것은, 느타리 버섯 유래의 본 제조예에서의 GABA 함량 증가는 단순히 느타리 버섯 유래의 GABA이거나, 느타리 버섯 유래의 glutamate가 GABA로 전환된 것이 아님을 알 수 있다. Compared with Comparative Example 1 and Comparative Example 4, the increase in the content of GABA and glutamate in Production Example 2 in comparison with the difference in the content of GABA and glutamate in the early stage of aging indicates that the increase in GABA content in this preparation derived from oyster mushroom It can be seen that it is not simply GABA derived from oyster mushroom, nor is glutamate derived from oyster mushroom converted to GABA.
Claims (6)
Wherein the fermented product is fermented at 20 to 40 ° C after inoculation with a lactic acid bacterium in a mixed seasoning prepared by mixing water extract of oyster mushroom or mushroom mushroom with seasoning of Kimchi and then fermenting the fermented seasoning to a pickled Chinese cabbage. Preparation method of content.
상기 유산균은 Lactobacillus sp., Lactococcus sp. 또는 Leuconostoc sp.인 것을 특징으로 하는 GABA 고함량 김치의 제조 방법.
The method according to claim 1,
The lactic acid bacteria are Lactobacillus sp. , Lactococcus sp. Or Leuconostoc sp. ≪ / RTI > wherein the method comprises the steps of:
상기 유산균은 Lactobacillus hilgardii, Lactobacillus sakei, Lactobacillus paracasei, Lactobacillus rennini, Lactobacillus buchneri, Lactobacillus brevis, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactococcus Lactis, Leuconostoc mesenteroides, Leuconostoc lactis로 이루어진 군으로부터 선택된 하나 이상인 것을 특징으로 하는 GABA 고함량 김치의 제조 방법.
3. The method of claim 2,
Wherein the lactic acid bacteria are at least one selected from the group consisting of Lactobacillus hilgardii , Lactobacillus sakei , Lactobacillus paracasei , Lactobacillus rennini , Lactobacillus buchneri , Lactobacillus brevis , Lactobacillus plantarum , Lactobacillus rhamnosus , Lactococcus lactis , Leuconostoc mesenteroides , Leuconostoc lactis . ≪ / RTI >
상기 배합 양념의 발효는 12~48시간 이루어지는 것을 특징으로 하는 GABA 고함량 김치의 제조 방법.
The method according to claim 1,
Wherein the fermentation of the mixed seasonings is carried out for 12 to 48 hours.
상기 김치는 0~25℃에서 숙성하는 것을 특징으로 하는 GABA 고함량 김치의 제조 방법.
The method according to claim 1,
Wherein the kimchi is aged at 0 to < RTI ID = 0.0 > 25 C. < / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160008856A KR101778260B1 (en) | 2016-01-25 | 2016-01-25 | Preparation Method for Kimchi with High GABA Content |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160008856A KR101778260B1 (en) | 2016-01-25 | 2016-01-25 | Preparation Method for Kimchi with High GABA Content |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170088668A KR20170088668A (en) | 2017-08-02 |
KR101778260B1 true KR101778260B1 (en) | 2017-09-13 |
Family
ID=59651962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160008856A Active KR101778260B1 (en) | 2016-01-25 | 2016-01-25 | Preparation Method for Kimchi with High GABA Content |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101778260B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210084899A (en) | 2019-12-30 | 2021-07-08 | 조선대학교산학협력단 | Composition for increasing gamma-amino butyric acid content of mushroom |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102121608B1 (en) * | 2019-09-30 | 2020-06-10 | 우석대학교 산학협력단 | Method for manufacturing functional amino acid-enriched kimchi |
CN113355374B (en) * | 2020-11-26 | 2022-11-22 | 内蒙古伊利实业集团股份有限公司 | Method for synthesizing B vitamins by fermenting lactobacillus paracasei ET-22 and application |
CN113355375B (en) * | 2020-11-26 | 2022-11-22 | 内蒙古伊利实业集团股份有限公司 | Method for synthesizing B vitamins by fermenting lactobacillus paracasei K56 and application |
KR102677848B1 (en) * | 2021-09-02 | 2024-06-24 | 충청북도(관리부서:충청북도 농업기술원) | Probiotics for fermenting kimchi and kimchi using the same |
-
2016
- 2016-01-25 KR KR1020160008856A patent/KR101778260B1/en active Active
Non-Patent Citations (1)
Title |
---|
Li et al. Production of gamma-aminobutyric acid by Lactobacillus brevis NCL912 using fed-batch fermentation. Microbial Cell Factories. 2010, 9:85* |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210084899A (en) | 2019-12-30 | 2021-07-08 | 조선대학교산학협력단 | Composition for increasing gamma-amino butyric acid content of mushroom |
Also Published As
Publication number | Publication date |
---|---|
KR20170088668A (en) | 2017-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6970226B2 (en) | New fermented seasoning composition | |
Cho et al. | Production of high γ-aminobutyric acid (GABA) sour kimchi using lactic acid bacteria isolated from mukeunjee kimchi | |
KR101778260B1 (en) | Preparation Method for Kimchi with High GABA Content | |
Seok et al. | Production and characterization of kimchi with enhanced levels of $\gamma $-aminobutyric acid | |
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
KR100716133B1 (en) | Garlic material for health promotion and its manufacturing method with mild irritant flavor | |
KR102431335B1 (en) | Novel starter of Lactobacillus fermentum EFEL6800 with probiotic activity | |
JP2010252660A (en) | Seaweed fermentation composition and method for producing the same | |
KR101817226B1 (en) | Flat fish sikhae containing high GABA and method for preparing thereof | |
CN105876673A (en) | Method for preparing functional minced small yellow croaker product by utilizing mixed-bacterium fermentation | |
KR20160069119A (en) | Fermentation Process of a Garlic Using New Strain of Bacillus subtilis | |
KR101802400B1 (en) | Processed salt containing lactobacillus gaba and the method for manufacturing processed salt containing lactobacillus gaba thereof | |
KR20150032379A (en) | Lactobacillus brevis 4-12 having GABA production capacity and methods for preparing Kimchi comprising the same | |
KR101540746B1 (en) | Producing method of conjugated linoleic acid | |
KR101852120B1 (en) | Method for Manufacturing Functional Healthy Sauce of Cold Raw Fish Soup | |
Shin et al. | Ethnic fermented foods and beverages of Korea | |
KR101540743B1 (en) | Producing method of conjugated linoleic acid and bean fermented food | |
Subardjo | Black tea water kefir beverage: a thesis submitted in partial fulfilment of the requirement for the degree of Master of Food Technology, Massey University, Albany, New Zealand | |
Sahu et al. | Starter cultures: an insight into specific applications in flavoring and health promotion | |
KR102794231B1 (en) | Method for manufacturing white kimchi cultured with intestinal lactic acid bacteria and white kimchi manufactured thereby | |
KR20140012441A (en) | Preparation of kimchi used enterococcus sp. koam153 | |
KR101754625B1 (en) | Process for preparing fermented vinegar using Kimchi | |
KR102656647B1 (en) | Soy sauce comprising fermented Saccharina japonica | |
JP4921721B2 (en) | Production method of functional food | |
KR100762709B1 (en) | Sodium chloride-free miso composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160125 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170327 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170623 |
|
PG1501 | Laying open of application | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170907 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20170908 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20210908 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20220915 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20230907 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20240626 Start annual number: 8 End annual number: 8 |